These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2724295)

  • 21. The pharmacology of vesamicol: an inhibitor of the vesicular acetylcholine transporter.
    Prior C; Marshall IG; Parsons SM
    Gen Pharmacol; 1992 Nov; 23(6):1017-22. PubMed ID: 1487110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photoaffinity labeling of the vesamicol receptor of cholinergic synaptic vesicles.
    Rogers GA; Parsons SM
    Biochemistry; 1993 Aug; 32(33):8596-601. PubMed ID: 8357803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent occultation of the vesamicol receptor.
    Rogers GA; Parsons SM
    Neuroreport; 1990 Sep; 1(1):22-5. PubMed ID: 1966599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A further study of the neuromuscular effects of vesamicol (AH5183) and of its enantiomer specificity.
    Estrella D; Green KL; Prior C; Dempster J; Halliwell RF; Jacobs RS; Parsons SM; Parsons RL; Marshall IG
    Br J Pharmacol; 1988 Apr; 93(4):759-68. PubMed ID: 3260527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of acetylcholine storage by acetylcholine analogs in vitro.
    Rogers GA; Parsons SM
    Mol Pharmacol; 1989 Aug; 36(2):333-41. PubMed ID: 2770706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical evidence that acetylcholine release from cholinergic nerve terminals is mostly vesicular.
    Michaelson DM; Burstein M
    FEBS Lett; 1985 Sep; 188(2):389-93. PubMed ID: 4029394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AH5183 and cetiedil: two potent inhibitors of acetylcholine uptake into isolated synaptic vesicles from Torpedo marmorata.
    Diebler MF; Gaudry-Talarmain YM
    J Neurochem; 1989 Mar; 52(3):813-21. PubMed ID: 2521893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compared effects of two vesicular acetylcholine uptake blockers, AH5183 and cetiedil, on cholinergic functions in Torpedo synaptosomes: acetylcholine synthesis, choline transport, vesicular uptake, and evoked acetylcholine release.
    Gaudry-Talarmain YM; Diebler MF; O'Regan S
    J Neurochem; 1989 Mar; 52(3):822-9. PubMed ID: 2493069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local anaesthetic activity of vesamicol in the electric organ of Torpedo.
    Girod R; Loctin F; Dunant Y
    Eur J Pharmacol; 1991 Mar; 195(1):1-9. PubMed ID: 1648490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A critical histidine in the vesicular acetylcholine transporter.
    Keller JE; Parsons SM
    Neurochem Int; 2000 Feb; 36(2):113-7. PubMed ID: 10676874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinacrine and 2-(4-phenylpiperidino)cyclohexanol (AH5183) inhibit acetylcholine release and synthesis in rat brain slices.
    Jope RS; Johnson GV
    Mol Pharmacol; 1986 Jan; 29(1):45-51. PubMed ID: 3945227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of veratridine on miniature endplate current amplitudes at the rat neuromuscular junction and acetylcholine uptake by Torpedo synaptic vesicles.
    Pemberton KE; Nguyen ML; Prior C; Parsons SM; Marshall IG
    Brain Res; 1995 Feb; 671(2):267-74. PubMed ID: 7743214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetic and equilibrium characterization of vesamicol receptor-ligand complexes with picomolar dissociation constants.
    Rogers GA; Kornreich WD; Hand K; Parsons SM
    Mol Pharmacol; 1993 Sep; 44(3):633-41. PubMed ID: 8371715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterization of the vesamicol analogue (+)-[(125)I]MIBT in primate brain.
    Staley JK; Mash DC; Parsons SM; Khare AB; Efange SM
    Eur J Pharmacol; 1997 Nov; 338(2):159-69. PubMed ID: 9455998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vesamicol analogues as sigma ligands. Molecular determinants of selectivity at the vesamicol receptor.
    Efange SM; Mach RH; Smith CR; Khare AB; Foulon C; Akella SK; Childers SR; Parsons SM
    Biochem Pharmacol; 1995 Mar; 49(6):791-7. PubMed ID: 7702637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photoaffinity labeling of the acetylcholine transporter.
    Rogers GA; Parsons SM
    Biochemistry; 1992 Jun; 31(25):5770-7. PubMed ID: 1319201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vesamicol blocks the recovery, by recycling cholinergic electromotor synaptic vesicles, of the biophysical characteristics of the reserve population.
    Rícný J; Whittaker VP
    Biochim Biophys Acta; 1993 Jun; 1148(2):234-8. PubMed ID: 8504117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linkage of the acetylcholine transporter-vesamicol receptor to proteoglycan in synaptic vesicles.
    Bahr BA; Noremberg K; Rogers GA; Hicks BW; Parsons SM
    Biochemistry; 1992 Jun; 31(25):5778-84. PubMed ID: 1319202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and characterization of a nonvesicular vesamicol-binding protein from electric organ and demonstration of a related protein in mammalian brain.
    Hicks BW; Rogers GA; Parsons SM
    J Neurochem; 1991 Aug; 57(2):509-19. PubMed ID: 1649250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of cysteines reveals linkage to acetylcholine and vesamicol binding sites in the vesicular acetylcholine transporter of Torpedo californica.
    Keller JE; Bravo DT; Parsons SM
    J Neurochem; 2000 Apr; 74(4):1739-48. PubMed ID: 10737633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.